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Being a global health concern, dental fear and anxiety is estimated to affect at least one in ten 
individuals all around the globe. Ensuing the vicious circle of dental fear comes detrimental 
outcomes in quality of life. Despite the wide range of knowledge concerning the environmental 
factors that contribute to the acquisition of dental fear and anxiety, the prevalence has not 
decreased, giving researches a possibility to highlight other concomitant etiological factors. The 
possible hereditary or genetic component is most recently being explored, although facing 
tremendous dynamical elements in order to substantially delineate its role.  
The purpose of this review was to explore, reflect and call attention to the current knowledge 
of the genetic involvement of dental treatment fear and anxiety. Although findings mostly stress 
the relation between dental fear to other phenotypes giving rise to individual vulnerability, there 
are studies disclosing suggestive heritability rates for dental fear and anxiety.    
 







Por ser um problema global de saúde, estima-se que o medo e a ansiedade das idas ao dentista 
afetem pelo menos um em cada dez indivíduos. O círculo vicioso deste medo, resulta em 
prejuízos para a qualidade de vida do indivíduo. Apesar do amplo conhecimento sobre os fatores 
ambientais que contribuem para a aquisição do medo e ansiedade no tratamento odontológico, 
a sua prevalência não diminuiu, o que permite evidenciar outros fatores etiológicos 
concomitantes. A possível componente hereditária ou genética tem sido explorada mais 
recentemente, embora enfrente elementos dinâmicos para delinear substancialmente o seu 
papel.  
O objetivo desta revisão foi explorar, refletir e chamar a atenção para o conhecimento atual 
sobre o envolvimento genético no desenvolvimento do medo e da ansiedade no tratamento 
odontológico. Embora as descobertas incluam principalmente a relação entre o medo da ida ao 
dentista e outros fenótipos que dão origem à vulnerabilidade individual, há estudos que revelam 
taxas de herança sugestivas para este tipo de medo e ansiedade. 
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Fear and anxiety associated with dental treatments are long known global public health 
concerns. These attributes have also proved to be detrimental in terms of neglective compliance 
to dental treatments and dental care behaviour resulting in reduced oral health and negative 
impact on quality of life, following “the cycle of dental anxiety” (Berggren, 1984).   
Even though there is an overall concordance amongst various authors that the aetiology is 
multifactorial (Beaton et al., 2013), the most widely discussed theme regarding its origin is 
exogenous and cognitive, most easily summarized in “Rachmanns three pathways of fear”, 
where the acquisition of the fear rises from aversive past experiences (Pavlovian conditioning), 
(Milosevic & McCabe, 2015),  vicarious (seeing) or informative (hearing) pathway.  
Dental practitioners have over the years adapted various methods and protocols to overcome 
the phenomenon (Minja & Kabahuka, 2018). Nevertheless, looking at the statistics of dental 
anxiety over 50 years, researchers could not find a decrease in the population (Smith & Heaton, 
2003). The efficacy of the existing management and cognitive treatment remains in controversy, 
thus regressing to the multifactorial aetiology, opening up the possibility of highlighting other 
aspects.  
Researchers have suggested possible genetic variabilities in which an individual may be more 
or less predisposed to suffer from dental anxiety or fear. These genetic findings are often 
entangled with one of the following neuropsychological dynamics: fear, pain or 
temperamental/personality characteristics. Considering that the heritable component of some 
personality disorders is remarkably high, such as General Anxiety Disorder (GAD) (McNeil et 
al., 2001) being dental anxiety one of its related branches, can possibly result from one of the 
genetic factors involved. Digging further into inheritance patterns in twins, Ray et al. (2010) 
showed a notable difference in heritability of dental anxiety/fear between girls and boys. This, 
in accordance with other findings, suggested higher numbers of dental anxiety or fear in females 
than in males (Randall et al., 2017; Zinke et al., 2019). Suggestively there is moderate 
heritability in specific phobias and candidate gene associations have been presented (Kendler 
et al., 1999; Gratacòs et al., 2001). Until today, studies have succeeded to outline a twice as 
high predictability to dental avoidance seeking behaviour, depending on the existence of a 
Melanocortin 1 Receptor (MC1R) gene variant (Binkley et al., 2009; Randall et al., 2016b). 
Remarkably, Randall et al. (2016a) demonstrated results of 30% heritability of dental fear 




followed by another genome-wide-association-study where suggestive loci for dental fear 
associated phenotypes were presented (Randall et al., 2017).  
 
The aim of this review was to explore and highlight the current understanding and findings of 




The relevant published literature was found and collected through the databases of MEDLINE 
(via Pubmed), B-on, LILACS (through BVS) and VHL via BVS. The search was made by the 
controlled and structural use of vocabulary terms - namely MESH and DeCS (multilingual 
Health science descriptors). The keywords used for the search in mentioned databases were 
combined by boolean modifiers/operators “AND” and “OR”. The timeline used was set for 
1980 until 2020. Articles included were first chosen upon the abstract, followed by thorough 
exploration of the whole work, including meta-analyses, research articles or reviews. All those 
articles not aiming the purpose of this study were excluded upon reading the abstract together 
with those articles not written in English.  
 
    
 
  





II.1. Definitions and Prevalence 
The association of negative feelings toward dental settings or treatments is termed “Dental fear 
and anxiety”, abbreviated to DFA (Campbell, 2017). The terms fear and anxiety are used 
interchangeably in numerous literatures, although the knowledge of how to differentiate anxiety 
from fear (including their different types) that might be experienced is important. It helps the 
dental team to build empathy with the patient and predict their behaviour patterns. However, in 
this context, to be able to distinguish between these two emotions is very important to try 
delimiting the underlying hypothetical psychogenetic components. 
 
i. Terminology 
Evolutionary viewed, both fear and anxiety promote survival (Craske, 2003). Fear is defined as 
the reaction towards immediate danger which involves the release of adrenaline and stimulation 
of the fight-or-flight response. By these means, dental fear is seen as the reaction provoked by 
a stimulus which has been interpreted as dangerous or threatening such as a dental drill. Anxiety 
is described as a more complex state of mind. It is the reaction towards a potential or 
hypothetical danger often associated with the sensation of incapacity to control the upcoming 
situation. In dental perspective this can reflect the distress felt prior upon a dental visit. 
(Campbell, 2017). Dental phobia, which also falls under the categorizations of specific phobia 
subtypes, marks an overly expressed and exaggerated, prolonged state of anxiety towards a 
frightful situation or object related to dentistry. Blood-injury-injection (BII) fear or phobia is a 
prominent fear or anxiety related to visualizing blood, an injection, an invasive medical 
procedure or associated to an injury (Milosevic & McCabe, 2015). It is also worth mentioning, 
that there are insufficient findings concerning BII fear and phobia that allow its separate 
classification from dental fear and phobia and therefore can merge into the upcoming review 
(LeBeau et al., 2010). 
 
ii. General evidences 
There are several assessment methods for diagnosing and measuring DFA. Amongst others, 
there is the Corah’s Dental Anxiety Scale (DAS) and the Modified Dental Anxiety Scale 
(MDAS) to quantify dental anxiety as low, moderate or high. According to these scales, severe 
dental anxiety implicates the possibility of phobia (Humphris et al., 1995).  




Authors suggest a higher prevalence as well as a greater intensity of DFA in females than in 
males. Evidence repeatedly suggests that the prevalence of DFA declines with age (Ray et al., 
2010; Klingberg, 1995; Randall et al., 2017), although that might not be the case in dental fear 
intensity which seems to remain stable. Keeping in mind that the onset of anxiety, fear or 
phobias can occur at any age, the estimated age of onset for BII phobia is five to nine years old 
(Milosevic & McCabe, 2015). In the case of dental fear and anxiety, Klingberg (1995) estimated 
its accentuated existence between four and nine years of age, although acquisition of fear, 
phobias and anxieties are thought to be highly dependent on the cognitive developmental state 
of the child and therefore can be strongly individual (Milosevic & McCabe, 2015).  
Estimating the prevalence of and diagnosing dental anxiety and fear in the overall population 
comes with some interpretation obstacles due to the various assessment methods, questionnaires 
and geographical discrepancies involved, along with the various aspects of the human psyche 
(Moore, 1991). Nevertheless, the worldwide prevalence reports that at least one in ten children 
has some level of DFA. In northern countries the prevalence seems to be slightly lower (Cianetti 
et al., 2017). 
 
iii. The circle of dental fear and quality of life 
On an individual level, DFA has shown detrimental outcomes and negative impact on the 
quality of life. In what is called “the vicious cycle of dental fear”, Berggren (1984) explained 
the crucial role of DFA in the avoidance seeking behaviour which would propagate a path where 
treatment becomes procrastinated until symptom driven. This would in turn, increase the 
likelihood of being subjected to more invasive, discomforting treatment and finally ascertain 
their negative presumptions of dentistry, regressing to the first state of avoidance behaviour 
again (De Jongh et al., 2011). As such, patients suffering from DFA consecutively tend to have 
lower overall oral health that affects their life quality. In many cases, this change in life quality 
is not only at the physiological and functional level but also emotional (feelings of guilt and 
shame) and social. 
 
iv. Types of fear in dentistry 
Fear of blood-injection-injury is often present in individuals highly attentive and fearful of 
invasive medical procedures such as dental extractions. Dental fear and phobia have emerged 
into this classification due to the largely similar aspects.  




Fear of pain, also known as agliophobia, may play a crucial role in the development of DFA 
which will be more thoroughly discussed later. Pain itself is essential for survival. It results in 
the retreat from a potentially harmful situation to protect oneself physically. The studies are 
incomplete regarding the original source of fear of pain, whether it is the painful sensation that 
causes the fear, the activities that may lead to the pain or the thought of a painful reinjury. 
However, the outcome of this fear is thought to be shown as excessive focus on painful stimuli, 
restrictive body motions or avoidance seeking behaviours from activities. 
Fear of the dentist is another important factor which may lead to dental fear and anxiety. 
Perceiving negative judgement from the dental team, not trusting the dental professional or not 
establishing a fundamental patient-operator relationship could produce anxiety in relation to 
dental visits. Not only is the correct, adjustable use of vocabulary advisable for correct 
interaction with the patient, but additionally the body language amongst other factors 
(Campbell, 2017). 
Fear of dental instruments is one of the reported reasons why individuals refrain from visiting 
the dentist. This includes the shape of the instruments that could be perceived as dangerous or 
potentially harmful or the sound produced during the treatment (Abdulrahman et al., 2016). 
Other fears have indeed been included in the context of DFA, such as fear of vomiting, fear of 
shame, fear of the dental chair amongst others. However, the restrictions in the number of pages 
would not allow further elaboration on all these aspects.  
 
v. Aetiology 
The aetiology of dental fear and anxiety is considered multifactorial and very complex, made 
up of both exogenic and endogenic aspects. The factors considered exogenous are generally 
summarized in “Rachman's three pathways of fear” (Milosevic & McCabe, 2015) namely 
conditioning, vicarious and verbal. 
The conditioning pathway suggests that a previously aversive dental experience which once 
stimulated an anxiety or fearful response is responsible for the association between those 
feelings and the trigger. 
The vicarious pathway states that the fear or anxiety does not necessarily result from personal 
past experiences (thus is indirect). Seeing someone else experiencing that fear can be enough 
to trigger the feeling. For instance, a child can acquire DFA only by seeing the parent having a 
bad experience. 




At last, in the verbal pathway, also indirect, hearing frightful stories about how others 
experienced the dentist may contribute to the development of DFA.  
These theories, although widely accepted, are not fully substantial. Trying to predict specific 
phobias, by solely relying on these cognitive modelling experiences did not manage to account 
for the total existing variance even closely (Oosterink et al., 2009). This study raised the same 
question as in the work of Smith & Heaton (2003) that showed, over the past 50 years, no 
reduction of DFA in the population, despite the rising awareness and implementation of 
adjustments included in good dental practice. Another inevitable doubt arises from the fact that 
not everyone suffering from DFA remembers having a bad experience, whether directly or 
indirectly. Neither does everyone with a bad dental experience develop DFA (Campbell, 2017).  
Nowadays, evolutionary aspects of inheriting traits, together with genetic vulnerability studies 
and hypothetical linked genes or temperamental associations are being brought into closer 
attention. A growing body of scientific research supports the proposition that genes and innate 
inherited mechanisms perhaps have more significance in the development of DFA than 
formerly recognized. 
 
II.2. Psychogenetics of dental fear and anxiety  
 
i. “Natural selection - on the origin of species” 
From a Darwinist point of view, Gray (1982;1987) portrayed a theory of “inherited phobia 
proneness” on how mankind, via natural selection, has obtained an inherited predisposition to 
create phobic reactions towards specific stimuli. Correspondingly, in the “diathesis stress model 
of illness” Monroe and Simons (1991) described the aetiology of specific psychological 
behaviours or diseases (such as irrational fears or phobias), as a result of environmental events 
(stressor) in addition to an already existing genetic predisposition (diathesis).  
Again Kendler et al. (1999) obtained results supporting these underlying approaches, 
emphasizing that genetic factors together with environmental ones are needed to shape clinical 
phobia. In the case of BII, an outstanding observation that aims the distinction from other types, 
is that nearly 70% of existing cases have a family member with the same diagnosis (Beidel & 
Turner, 2005). In BII-phobia the physiological response is characterized by two phases. The 
first one consists of the physiological acceleration in heart rate and blood pressure, which is a 
common response of most phobias. The second phase (which quickly follows the first one) 
demonstrates a drastic decrease of the same, resulting in syncope (75% have a history of 




fainting) or feelings of it. This physiological response shows a heritable pattern. It is believed 
that a dysregulation of the autonomous nervous system makes these individuals prone to 
fainting upon facing the stimuli (Milosevic & McCabe, 2015). The estimated heritability rates 
of BII phobias, varies between different studies from 33 to 59% (Milosevic & McCabe, 2015; 
Van Houtem et al. 2013). Van Houtem et al. (2013) accounted for the highest rate amongst 
specific phobia subtypes.  
Ray et al. (2010) conducted a longitudinal study encompassing 2000 Swedish twins over three 
years with the aim of investigating the hypothesized heritable component of dental fear and 
anxiety. The participants would once at the start and once at the end of the timeline, answer 
three questions with yes or no regarding DFA and one question about the fear intensity. The 
findings suggested the presence of a genetically inherited component of dental fear, higher in 
females than in males. The heritability of DFA seemed to decline with age for both genders, 
whereas the dental fear intensity remained stable in both. This is supported by other studies 
attempting to conceptualize heritability rates where dental fear demonstrates 30% heritability 
and has a higher prevalence in females than in males (Randall et al., 2016a). 
 
ii. Fear of pain 
Pain itself, promotes survival and has a protective mechanism in terms of refraining the body 
from harm. The perception of pain appears to be highly individual and includes both 
physiological and psychological aspects that perhaps are genetically mediated, giving rise to a 
broad variety of pain sensitivity that can be measured (Nielsen et al., 2008; Nielsen et al., 2009; 
Rosier et al., 2002). The reasons for developing fear towards pain is disputable throughout the 
literature, encompassing speculations whether it is due to higher pain sensitivity, amongst 
others (Randall et al., 2017; Binkley et al., 2009).  Experiencing pain and particularly higher 
levels of pain during dental treatment, is more likely to be reported from dental anxious subjects 
than those without dental anxiety (Maggirias & Locker, 2002; Vassend, 1993). Individuals with 
higher anxiety sensitivity (a sensation that pain may be dangerous) tend to additionally report 
more fear of pain than their counterparts (Binkley et al., 2009). Arising consensus states that 
some temperamental traits give higher occurrence or are associated with DFA in adults, such 
as anxiety and neuroticism (Hakeberg et al., 2001; Vassend et al., 2011) or shyness and 
inhibition in children (Klingberg & Broberg, 2007). These findings leaned towards the 
perception that perhaps DFA should be regarded as an additional vulnerability and to an extent 
heritable, in some general fears or anxiety disorders (Berggren, 1992). Amongst other fears, 




fear of pain is perhaps particularly closely related to DFA, given that fear of severe pain in 
orofacial pain patients is significantly higher than observed in controls (McNeil et al., 2001) 
and candidate genes have been presented, implying a higher tendency to its development 
(Binkley et al., 2009). The perception of pain might be influenced by variants of the gene 
encoding the melanocortin 1 receptor (MC1R gene) that also plays a role in the cascade of 
processing pain, fear and anxiety in the brain. There are five receptors of melanocortin namely: 
MC1R, melanocortin 2 receptor, melanocortin 3 receptor (MC3R), melanocortin 4 receptor 
(MC4R) and melanocortin 5 receptor (Switonski et al., 2013). The most frequent receptors 
found in the central nervous system are MC3R and MC4R, however, they have the same affinity 
for alpha-melanocyte-stimulating hormone as MC1R (Abdel-malek, 2001). The melanocortin 
system is found related to anxiety-like behaviour and there is a possibility that individuals 
carrying the MC1R gene could simultaneously express other variants of the melanocortin 
receptors (Chaki and Okuyama., 2005; Binkley et al., 2009). The effects of analgesia can be 
caused by the presence of the allelic variants more commonly expressed in the brain (Mogil, 
2005).  
The presence of these allele variants predisposes these individuals to the development of dental 
fear. Moreover, since the MC1R gene is associated with individuals with red hair, these 
individuals (or dark haired caucasians with a variant of this gene, which counted for almost one 
quarter of the dark haired included) were twice as likely to have dental avoidance seeking 
behaviour than those with none. Supporting this study is a cross-sectional study with 817 
participants genotyped for the presence of a single nucleotide polymorphism (SNP) (Randall et 
al., 2016b). Randall et al. (2016b) not only succeeded in replicating the data where the presence 
of MC1R alleles predicted higher DFA, but also demonstrated that the fear of pain mediated the 
relation between the MC1R gene and dental fear. In opposition to the consent where heightened 
pain sensitivity would lead to a higher fear of pain (or vice-versa) and predispose these 
individuals to DFA, there are studies showing close to zero correlation between DFA and pain 
sensitivity (Vassend et al., 2011). Instead of an increase in pain sensitivity, these authors 
address the possibility of correlating it with lower levels of pain tolerance (supposedly more 
related to behavioural states, personality traits and ongoing situations). According to Randall, 
et al. (2016b), dental fear can possibly be maintained because of the fear of pain, regardless of 
whether there exists actual dental pain or not. The same authors, in another study, suggested 
heritability rates for dental fear and fear of pain by collecting data from a research program 
located in Northern Appalachia. A 34% heritability rate was suggested for fear of pain. The 
overall genetic impact on DFA and fear of pain, compromised in common genes, hypothetically 




varies between 40-72% (Randall et al., 2016a). Heritability of dental fear was estimated to 30% 
which is slightly lower than the heritability for fear of pain. This moderate rate of heritability is 
coincident with other contemporary measures (Ray et al., 2010). Among the presented 
subscales, “fear of specific dental stimuli” and “fear of medical/dental pain” were the ones with 
highest estimates, although “fear of severe pain” also maintained its heritable significance after 
including the household effect in the variance (Randall et al., 2016a).  
 
iii. Candidate genes and locus 
Taken into account the previous studies suggesting that fear of pain is genetically closely related 
to DFA but leading to different phenotypes (Randall et al., 2016a) and the fact that fear of dental 
pain intensity maintained stability in the studied population (Ray et al., 2010), one might 
question if specific genes can prime individuals to peculiar levels of fear of pain or more 
specifically fear of medical/dental pain.  
In the first GWAS study, made to identify plausible genes with possible relations to fear of 
pain, three subscales were included: fear of minor pain, fear of severe pain and fear of 
medical/dental pain (Randall et al., 2017). The study included 990 participants from a research 
program in Northern Appalachia, between 12-74 years of age and tested 8.5 M genes for 
association with fear of pain. Fear of minor pain showed three associations with genetic loci on 
a genome-wide level. The proposed most significant locus was located on chromosome 8 
(8q24.13), close to the gene encoding de transmembrane protein 65 (TMEM65 gene) (Randall 
et al., 2017). 
Additionally, another significant locus was found on chromosome 8, this time on the short arm 
(8p21.2) close to the gene encoding the neurofilament medium protein (NEFM gene) and the 
gene encoding the neurofilament light protein (NEFL gene). The SNP rs73547001, for this 
locus on chromosome 8, was found in LOC105379330, a LOC gene, hence undefined and is 
likely to be a pseudogene (Randall et al., 2017).  
The third locus (6q26), with leading SNP rs73782827, was located near the gene encoding the 
enzyme 1-acylglycerol-3-phosphate O-acyltransferase 4 (AGPAT4 gene) and the gene encoding 
Parkin RBR3 ubiquitin protein ligase (PARK2 gene). Other associations of genetic loci for fear 
of medical/dental pain were additionally detected, however these did not reach the threshold 
for genome-wide significance (Randall et al., 2017).  
Possibly, fear of minor pain might be the phenotype more prominent in already pain fearful 
individuals, in contrast to fear of severe pain or fear of dental pain which could be more 




normative. Furthermore, fear of minor pain could result in fear of minor dental procedures and 
thus, dental avoidance seeking behaviour (Randall et al., 2017). 
Another noteworthy possibility is the suggested correlation of the serotonin-transporter-linked 
polymorphic region (5-HTTLRP) polymorphism and DFA (Franćeski et al., 2018). 5-HTT, a 
serotonin-reuptake-transporter, is codified by the SLC6A4 gene (solute carrier family 6, 
member 4) and localized on chromosome 17 (17q11.1-q12). Variants on its promoter region 
result in changes in serotonin activity. This polymorphic region has some functional allele 
variations such as the S (for Short) insertion of 14 sequence repeats of 20-23 bp and the L 
(Long) insertion of 16 sequence repeats of the same length. It was found that the presence of 
the S allele results in decreased transcription of this gene, resulting in lower serotonin reuptake 
(Heils et al., 1995; Heils et al., 1996). 
The serotonin transporter as the name suggests, is responsible for the recycling of serotonin 
from the synaptic cleft back to the presynaptic neuron and consequently allows the reuse of 
serotonin, while terminating the effects produced by it. The neurotransmitter serotonin has to a 
large extent been known as the hormone of happiness, albeit fitting more than 14 receptor 
subtypes and being able to produce opposite effects, whether pre- or postsynaptically (Hoyer et 
al., 2002). The amount of serotonin reuptake transporters in human brain cells is believed to be 
inversely proportional to serotonin effects. For the same reason, multiple pharmacotherapeutics 
target the serotonin transporters to inhibit or reduce their binding to serotonin (Guimarães et 
al., 2010). Admitting after years of research, that the precise role of serotonin is not completely 
understood, the 5- HTTLPR gene polymorphism is thought to play a valid role in cerebral 
functioning, neural evolvement and behaviours such as negative emotions and increased anxiety 
(Hariri & Holmes, 2006). In some trials, the increased binding to 5-HTT in subjects with GAD 
has been reported (Wee et al., 2008), whereas other authors detected decreased 5-HTT binding 
correlated to anxiety (Maron et al., 2004). Moreover, there is a variety of studies that found a 
relationship between the S allele, which leads to less expression of the transporter, and anxiety 
related disorders or personality traits such as neuroticism (Gonda et al., 2008). 
Therefore, current literature addresses the importance of the S allele variant in anxiety related 
disorders and personality traits. Individuals with this type of disorders show the presence of this 
variant more frequently, especially in the homozygous (S/S) state. Supportive studies show that 
the S allele predicted higher neuronal activity in human brain amygdala as a result of frightful 
stimuli thus creating increased response towards stressful life events (Hariri et al., 2005). 
Franćeski et al. (2018) hypothesized that individuals carrying the S allele would have higher 
scores in the dental anxiety and fear assessment scales, which turned out to be correct in their 




study. They found a positive relationship between the S allele and DFA, supporting the studies 
where dental anxiety was partly submerged under the umbrella of broader anxiety disorders and 
neuroticism. 
Otowa et al. (2016), to cluster common genetic effects in anxiety disorders, conducted one of 
the largest genetic studies to that date. The GWAS study included 18,000 unrelated individuals 
in 9 different samples, with all these samples showing different genome-wide-significant 
regions. The researchers applied two distinct methodological strategies to identify the most 
common genetic effects that are common to all anxiety disorders. The included “anxiety 
disorders” were general anxiety disorder, panic disorder, agoraphobia, social phobia and 
specific phobia. One of the methods used, was based on the contrast between case-control and 
showed the strongest relation on the non-coding locus 3q12.3. This locus has not been 
characterised so far. The second methodological strategy, based on quantitative phenotypic 
factor scores, identified three SNPs within genes of genome-wide significance on chromosome 
2 (2p21). The most significant of these three genes was the one coding for calmodulin-lysine 
N-methyltransferase (CAMKMT gene). The remaining mentioned genes were the gene coding 
for prolyl-endopeptidase-like protein (PREPL gene) which is a member of prolyl oligopeptidase 
family and ultimately the solute carrier family 3 member 1 (SLC3A1) gene, encoding the heavy 
chain of an amino acid transporter. This transporter is involved in the high-affinity, sodium-
independent transport of cystine and neutral and dibasic amino acids. All these genes were 
reported to be expressed in the brain and there is a suggested strong possibility of these genes 
being related to the risk factors for anxiety disorders. More extensive analysis and individual 
replication of these findings are needed to understand the role of the identified loci (Otowa et 
al., 2016). 
Gratacòs et al. (2001) presented an outstanding observation of the existence of a relationship 
between a duplication on chromosome 15(q24-26), referred to as DUP25, a segment of 14-17 
Mb, and several anxiety disorders. The individuals included in this study were from seven large 
families carrying joint laxity and DUP25. This study found that almost 80% of these individuals 
with the mentioned duplication, also had a phobic disorder. Moreover, testing a set of phobic 
patients unrelated to each other, the authors found the DUP25 in 68 of 70 individuals while for 
the control group only 14 in 189 showed the duplication. These findings have been reported 
amongst the strongest associations between a psychiatric disorder and genetic polymorphism. 
What was not found in this study, despite the remarkably high association, was the presence of 
any linkage. The duplication could not be explained by Mendelian inheritance, due to the lack 
of segregation of the markers within the duplication. Since it does not segregate in this way, it 




was suggested that the duplication is inherited in a non-strictly Mendelian fashion. It was 
additionally suggested, the existence of a large mosaic duplication resulting from a mutation 
occurring during cellular mitosis, that is not connected to neighbouring loci (Gratacòs et al., 
2001). Nevertheless, these findings lead to a large amount of questions amongst the researchers 
of the field who tentatively could not reproduce the same results (Tabiner et al., 2003; Zhu et 
al., 2004).  
Moreover, chromosomes incorporate material apart from but entangled with the DNA, which 
successively will be transmitted with it, the epigenome (Strachan & Read, 2011). This 
complement of proteins and chemical alterations will fluctuate at a specific locus and therefore 
affect the transgenerational descent of the epigenetic state, raising the possibility of several 
inherited epigenetic variants in association to the same genome. This common changeability in 
inherited epigenetic states to following germline is argued as a tool of phenotypic response to 




The presumption that pain sensitivity is measurable (Rosier et al., 2002), considering an 
adequate part of the broad individual variance genetically mediated (Nielsen et al., 2008; 
Nielsen et al., 2009), and that patients with high levels of DFA also demonstrate higher levels 
of pain during treatment (Maggirias and Locker, 2002) has been one tentative way to explore 
the cascade between genetic composition and DFA. This assumption that a higher pain 
sensitivity leads to a more painful dental treatment experience and consequently triggers the 
development of DFA, is perhaps the underlying assumption in Binkley’s study. The resistance 
to the effects of local analgesics on a population carrying the MC1R gene, makes them more 
susceptible to experience pain during dental treatment, hence more likely to develop dental 
anxiety (Binkley et al., 2009). In contrast to this belief, Vassend et al. (2011) expressed the 
possibility of a relation between DFA and pain tolerance, which could explain why these 
individuals appear to have a readiness to react fearfully and withdrawn. Hypothetically, if this 
concept is projected on the MC1R study, it could align with their result of higher dentalcare 
avoidance behaviour. Regarding their other results where feasible proportions of the genetic 
components of DFA suggestively overlap those for neuroticism, could those variants of the 
MC1R gene also play a role in the aetiology of neuroticism?  




Work of Binkley et al. (2009) expressed the possibility of simultaneously expressing other 
melanocortin receptors more frequently present in the brain, which could play a role in elevated 
levels of anxiety and consequently dental anxiety. However, none of the individuals in the 
studied population had any diagnosed psychological disorders (Binkley et al., 2009).  
Then, there is also the question of retrospective cognitive bias, the reliability of memory 
estimation of pain, not directly after treatment. In the evaluation of the MC1R gene variants, 
Randall et al. (2016b) highlighted how it is the fear of pain, not the pain per se, which mediates 
the association to DFA. In fact, an association between the MC1R gene and fear of dental pain 
was already brought into light by Binkley et al. (2009) and both these works suggested broader 
studies in the field should be done. Not to forget that the questionnaires are based on self-
evaluation and therefore may include levels of subjectivity. Higher levels of fear of pain seems 
to be consistent with orofacial pain subjects than those of control (McNeil et al., 2001) such as 
fear of severe pain or fear of medical/dental pain (Randall et al., 2016b). However, regarding 
results in the GWAS study (Randall et al., 2017), it comes off as partly diffuse since “fear of 
minor pain” was the only phenotype sub-category showing substantial associations to genetic 
loci on a genome-wide level. These two studies were both based on data collected from 
participants of the same research program in Northern Appalachia. Hence, the sample size and 
the relative demographic homogeneity of the analysed population could potentially either 
bypass true associations or/and bias the data of phenotypes respectively. To their favour, 
although the shortage of capacity in identifying low frequency gene associations, significant 
associations to three genetic loci were indeed found (Randall et al., 2017).  
There seems to be enough collective evidence for stating that the polygenic heritability is an 
important part of the fear of pain and ultimate development of dental fear. Detecting the 
presence of fear of pain could be an important aid for the correct detection and intervention of 
dental fear and phobia. 
Since pain is cognitively processed before being perceived, it leaves methodological difficulties 
in terms of distinguishing genes. In some situations, unpredicted genes have occasionally shown 
high associations with psychological disorders, but failed to be replicated by following studies, 
such as in the association of joint laxity and a DUP25, where 80% of tested patients showed a 
phobic disorder (Gratacòs et al., 2001; Tabiner et al., 2003; Zhu et al., 2004). 
Van Houtem et al. (2013), in their meta-analysis of twin studies, estimated BII phobia as the 
one with highest heritability rate amongst specific phobias, which is the one showing distinct 
physical signs in comparison to others. Perhaps this could serve as an indicative to the 
importance of genetic and biological qualifications. In the Otowa et al. (2016) study, the 




suggested genes reaching the threshold for genome wide significance, should be further 
analysed in relation to DFA in future studies. 
Some authors, such as Franćeski et al. (2018), found positive relations between dental anxiety 
and the 5- HTTLPR gene polymorphism, which may predispose these individuals to negative 
emotions and increased anxiety (Hariri & Holmes, 2006). Nevertheless, the literature in the 
field encompassing the serotonin system, such as the neurotransmission and the resulting effect 
on the human brain or behaviour, is widely contradictory per se. This is the case of the work of 
van der Wee et al. (2008) that found increased binding to 5-HTT in patients with GAD, and, on 
the other hand, other authors detected decreased 5-HTT binding correlated to anxiety (Maron 
et al., 2004). This can possibly be due to the fact that serotonin is able to produce opposing 
effects (Hoyer et al., 2002) and should be seen more accurately as multipotential. Moreover, 
Smith & Heaton (2003) did not find any decrease in dental anxiety in the population in their 
longitudinal study, but also did not find any increase, despite the fact that the overall general 
anxiety had risen.  
Ray et al. (2009) marked a strong difference between inheritance of DFA in girls and boys. 
Results of this study supported that girls are more vulnerable to DFA than boys, raising a 
comprehensive question. Literature addresses affirmatively that girls show DFA more than boys 
while others have suggested that boys are more likely to develop phobias than girls (Campbell, 
2017). If there is any gender difference, it comes together with multiple possible explanations 
to why it could appear in that manner. One of them being cultural gender roles, making boys 
more restrictive in terms of acknowledging fear, pain or associated emotions. As projected, all 
these findings even when highly reliable, come with individual variations and not surprisingly 
contradictive or supportive additional findings, giving room for tremendous pages of 
elaboration and future studies. 
 
The Rubix-cube of psychogenetics and DFA 
The complexity of the multifactorial aetiology of DFA (with emphasis on the multi) makes it 
extremely challenging to apprehend for anyone who is willing to try. With regards to the 
psychological means, one must face the dispute of psychological definitions in an already grey 
area of differential diagnostics to - many times invisible - symptoms. Only to be confronted 
with the enormous perplexity of the latest challenges in molecular biology and genetical 
dynamics in addition to all the influencing environmental factors. Single chromosome 
rearrangements and stable Mendelian inheritance patterns for complex psychological traits are 
most likely overruled in the presence of polygenic inheritance, pleiotropic genes and various 




loci with hypothetical associations. Measuring the complexity of DFA is relied on the adhesion 
to various factors that many times are contradictory to one another, namely the strict scientific 
objectivity in methods for many times diffuse and widely individual human psyche. (Moore, 
1991). No wonder that even monozygotic twins with supposedly 100% shared DNA, with the 
same familial and environmental factors, still have differences in behaviour, traits and 
personalities. Mendelian inheritance is not always sufficient for adequate explanation of the 
findings. As already mentioned above, the fluctuations in inherited epigenetic states to 
following germline, which is argued to be a phenotypic response to environmental influence, 
have lifted speculations about the underlying potential of its transmissions (Strachan & Read, 
2011). Could it, if stable, produce phenotypically fixed changes in a germline and by that also 
to the species, now inherited from parents to the next? Now, in the context of DFA, can the 
auxiliary epigenome be partly responsible for the variety of genome outcomes/expressions and 
the occasional associations found between some phenotypes and dental anxiety? Since 
inheritance of DFA seemingly is multifactorial, possibly polygenic with a sporadic penetrance 
only relying on Mendelian pathways would be indecisive. Nevertheless, finding a hypothetical 
epigenetic originator for inherited phenotype variants associated with DFA might challenge the 
borders of contemporary knowledge in all the involved areas of science. Still, the consistent 
march of development in science is not to be underestimated in what seems to be the rubix cube 
of dental fear and anxiety.  
 
IV. CONCLUSION 
The hypothesis that a specific inherited genotype could predict the actual future existence of 
DFA is widely discussed and findings are still scarce to allow such a conclusion.  
The sporadic associations found between inherited phenotypes and psychological means - 
related to, or of - DFA, are still unpolished and only give fragments of diverse possibilities. 
However, the general consensus seems to be in favour of a heritability and genetic component 
involved in the aetiology of DFA, with a relatively stronger influential role in some individuals. 
A number of candidate genes, particularly those encompassing fear of pain and psychological 
disorders such as neuroticism, do reflect a higher tendency to be associated with dental anxiety, 
fear and phobia.
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